Resource Library
- All Categories
- Acute Myeloid Leukemia
- Adults
- Allogeneic
- Anemia de Fanconi
- Anogenital
- Bone Marrow
- Bone marrow failure
- BRCA1
- BRCA2
- Breast Cancer
- BRIP1
- Cancer
- Cancer Risk
- Caregiver Resources
- Caregivers
- Case management
- Chemotherapy
- Clinical Trials
- Comprehensive Care Center
- Coping
- Counseling
- Covid-19
- Dermatology
- Diagnosis
- Diet
- Disability
- DNA
- DNA Repair
- Donor
- Endocrine
- Endocrinologist
- Endocrinology
- Esophagus
- Español
- FA Basics
- Family
- Family Planning
- FANC-A
- FANCJ
- FANCN
- FANCO
- FARF
- Fertility
- Finances
- Finances & Insurance
- Financial Support
- FMLA
- Food
- Français
- Fundraising
- Gastrointestinal
- Gene
- Genetic
- Gene Therapy
- Growth
- Growth Curve
- GvHD
- Haploidentical
- Head and neck
- Health Insurance
- Healthcare
- Help
- Hematology
- Hematopoietic
- hereditary
- HLA Matching
- HNSCC
- Hormones
- Infertility
- Inheritance
- Insurance
- IVF
- Lesions
- Maladie de Fanconi
- Medicaid
- Medicare
- Mental Health
- Monitoring
- Newly diagnosed
- Nutrition
- Oral Cancer
- PALB2
- Pathway
- Peer Support
- PGD
- PGT
- Post transplant
- Private Health Insurance
- Psychological
- Psychosocial Support
- Recursos en español
- Research
- Resilience
- Resources
- Science
- Screening
- Siblings
- Skin
- Skin Cancer
- Social Security Disability Insurance
- Squamous Cell Carcinoma
- SSDI
- SSI
- Stem Cell Donor
- Stem cells
- Steroids
- Success Rates
- Sun
- Sunscreen
- Support
- Support group
- Symptoms
- Transplant
- Transplant Center
- Transplant Resources
- Trauma
- Treatment
- Tumor
- Vaccine
- Vulvar Cancer
- Waivers
- Wellbeing
- Wellness
- What is FA
8 FA Cancer Facts
Cancer in Fanconi Anemia: A Clinical Overview
Dr. Jennifer Grandis (University of California, San Francisco) gives a clinical overview of cancer in Fanconi anemia patients, delivered at the 2023 FA Scientific Symposium.
“Power to U”: New campaign to manage the increased risk for oral cancer
We focus on early detection by providing all different kinds of support (including clinicians and individuals with FA)
The Future of FA Cancer Research: The Fanconi Anemia Cancer Consortium
FARF Scientific Director, Isis Sroka, talks about the newly developed Fanconi Anemia Cancer Consortium (FACC).
The NIH Center Comprehensive Program for Surveillance of Squamous Cell Carcinoma in Patients with FA
Neelam Giri and Sharon Savage cover a brief description of the protocol to prospectively evaluate and follow patients with FA at high risk of SCC with screening at regular intervals.